Skip to main content
PMC home page
Gut logoLink to Gut
. 2000 Oct;47(4):589–594. doi: 10.1136/gut.47.4.589

Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease

A CORFIELD 1, N MYERSCOUGH 1, R LONGMAN 1, P SYLVESTER 1, S ARUL 1, M PIGNATELLI 1
PMCID: PMC1728059  PMID: 10986224

Full Text

The Full Text of this article is available as a PDF (116.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal B., Gendler S. J., Longenecker B. M. The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Mol Med Today. 1998 Sep;4(9):397–403. doi: 10.1016/s1357-4310(98)01322-7. [DOI] [PubMed] [Google Scholar]
  2. Ajioka Y., Watanabe H., Jass J. R. MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J Clin Pathol. 1997 May;50(5):417–421. doi: 10.1136/jcp.50.5.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ajioka Y., Xing P. X., Hinoda Y., Jass J. R. Correlative histochemical study providing evidence for the dual nature of human colorectal cancer mucin. Histochem J. 1997 Feb;29(2):143–152. doi: 10.1023/a:1026485306044. [DOI] [PubMed] [Google Scholar]
  4. Aksoy N., Thornton D. J., Corfield A., Paraskeva C., Sheehan J. K. A study of the intracellular and secreted forms of the MUC2 mucin from the PC/AA intestinal cell line. Glycobiology. 1999 Jul;9(7):739–746. doi: 10.1093/glycob/9.7.739. [DOI] [PubMed] [Google Scholar]
  5. Aslam A., Spicer R. D., Corfield A. P. Children with Hirschsprung's disease have an abnormal colonic mucus defensive barrier independent of the bowel innervation status. J Pediatr Surg. 1997 Aug;32(8):1206–1210. doi: 10.1016/s0022-3468(97)90683-7. [DOI] [PubMed] [Google Scholar]
  6. Aslam A., Spicer R. D., Corfield A. P. Histochemical and genetic analysis of colonic mucin glycoproteins in Hirschsprung's disease. J Pediatr Surg. 1999 Feb;34(2):330–333. doi: 10.1016/s0022-3468(99)90202-6. [DOI] [PubMed] [Google Scholar]
  7. Baldus S. E., Hanisch F. G., Kotlarek G. M., Zirbes T. K., Thiele J., Isenberg J., Karsten U. R., Devine P. L., Dienes H. P. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms. Cancer. 1998 Mar 15;82(6):1019–1027. doi: 10.1002/(sici)1097-0142(19980315)82:6<1019::aid-cncr3>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  8. Baldus S. E., Zirbes T. K., Mönig S. P., Engel S., Monaca E., Rafiqpoor K., Hanisch F. G., Hanski C., Thiele J., Pichlmaier H. Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn. Tumour Biol. 1998;19(6):445–453. doi: 10.1159/000030036. [DOI] [PubMed] [Google Scholar]
  9. Bartman A. E., Sanderson S. J., Ewing S. L., Niehans G. A., Wiehr C. L., Evans M. K., Ho S. B. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999 Jan 18;80(2):210–218. doi: 10.1002/(sici)1097-0215(19990118)80:2<210::aid-ijc9>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  10. Biemer-Hüttmann A. E., Walsh M. D., McGuckin M. A., Ajioka Y., Watanabe H., Leggett B. A., Jass J. R. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum. J Histochem Cytochem. 1999 Aug;47(8):1039–1048. doi: 10.1177/002215549904700808. [DOI] [PubMed] [Google Scholar]
  11. Buisine M. P., Desreumaux P., Debailleul V., Gambiez L., Geboes K., Ectors N., Delescaut M. P., Degand P., Aubert J. P., Colombel J. F. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis. 1999 Feb;5(1):24–32. doi: 10.1097/00054725-199902000-00004. [DOI] [PubMed] [Google Scholar]
  12. Buisine M. P., Janin A., Maunoury V., Audié J. P., Delescaut M. P., Copin M. C., Colombel J. F., Degand P., Aubert J. P., Porchet N. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology. 1996 Jan;110(1):84–91. doi: 10.1053/gast.1996.v110.pm8536891. [DOI] [PubMed] [Google Scholar]
  13. Burdick M. D., Harris A., Reid C. J., Iwamura T., Hollingsworth M. A. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem. 1997 Sep 26;272(39):24198–24202. doi: 10.1074/jbc.272.39.24198. [DOI] [PubMed] [Google Scholar]
  14. Byrd J. C., Yan P., Sternberg L., Yunker C. K., Scheiman J. M., Bresalier R. S. Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology. 1997 Aug;113(2):455–464. doi: 10.1053/gast.1997.v113.pm9247464. [DOI] [PubMed] [Google Scholar]
  15. Carneiro F., Santos L., David L., Dabelsteen E., Clausen H., Sobrinho-Simões M. T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma. Histopathology. 1994 Feb;24(2):105–113. doi: 10.1111/j.1365-2559.1994.tb01288.x. [DOI] [PubMed] [Google Scholar]
  16. Carvalho F., Seruca R., David L., Amorim A., Seixas M., Bennett E., Clausen H., Sobrinho-Simões M. MUC1 gene polymorphism and gastric cancer--an epidemiological study. Glycoconj J. 1997 Jan;14(1):107–111. doi: 10.1023/a:1018573201347. [DOI] [PubMed] [Google Scholar]
  17. Corfield A. P., Myerscough N., Bradfield N., Corfield C. do A., Gough M., Clamp J. R., Durdey P., Warren B. F., Bartolo D. C., King K. R. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J. 1996 Oct;13(5):809–822. doi: 10.1007/BF00702345. [DOI] [PubMed] [Google Scholar]
  18. Corfield A. P., Myerscough N., Warren B. F., Durdey P., Paraskeva C., Schauer R. Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconj J. 1999 Jun;16(6):307–317. doi: 10.1023/a:1007026314792. [DOI] [PubMed] [Google Scholar]
  19. Corfield A. P., Warren B. F., Bartolo D. C., Wagner S. A., Clamp J. R. Mucin changes in ileoanal pouches monitored by metabolic labelling and histochemistry. Br J Surg. 1992 Nov;79(11):1209–1212. doi: 10.1002/bjs.1800791139. [DOI] [PubMed] [Google Scholar]
  20. David L., Nesland J. M., Clausen H., Carneiro F., Sobrinho-Simões M. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl. 1992;27:162–172. [PubMed] [Google Scholar]
  21. Filipe M. I., Linehan J. M., Durrant L. G., Price M. R., Smeeton N. C., Pathak S., Swallow D. M. Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesions to gastric carcinoma. Eur J Cancer Prev. 1996 Aug;5(4):287–295. doi: 10.1097/00008469-199608000-00009. [DOI] [PubMed] [Google Scholar]
  22. Garcia E., Carvalho F., Amorim A., David L. MUC6 gene polymorphism in healthy individuals and in gastric cancer patients from northern Portugal. Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1071–1074. [PubMed] [Google Scholar]
  23. Gendler S. J., Spicer A. P. Epithelial mucin genes. Annu Rev Physiol. 1995;57:607–634. doi: 10.1146/annurev.ph.57.030195.003135. [DOI] [PubMed] [Google Scholar]
  24. Hanski C., Born M., Foss H. D., Marowski B., Mansmann U., Arastéh K., Bachler B., Papenfuss M., Niedobitek F. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. J Pathol. 1999 Jul;188(3):304–311. doi: 10.1002/(SICI)1096-9896(199907)188:3<304::AID-PATH375>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  25. Hanski C., Bornhoeft G., Topf N., Hermann U., Stein H., Riecken E. O. Detection of a mucin marker for the adenoma-carcinoma sequence inhuman colonic mucosa by monoclonal antibody AM-3. J Clin Pathol. 1990 May;43(5):379–384. doi: 10.1136/jcp.43.5.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hanski C., Hanski M. L., Zimmer T., Ogorek D., Devine P., Riecken E. O. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res. 1995 Feb 15;55(4):928–933. [PubMed] [Google Scholar]
  27. Hanski C., Hofmeier M., Schmitt-Gräff A., Riede E., Hanski M. L., Borchard F., Sieber E., Niedobitek F., Foss H. D., Stein H. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol. 1997 Aug;182(4):385–391. doi: 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  28. Hanski C., Riede E., Gratchev A., Foss H. D., Böhm C., Klussmann E., Hummel M., Mann B., Buhr H. J., Stein H. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab Invest. 1997 Dec;77(6):685–695. [PubMed] [Google Scholar]
  29. Hiraga Y., Tanaka S., Haruma K., Yoshihara M., Sumii K., Kajiyama G., Shimamoto F., Kohno N. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer. Oncology. 1998 Jul-Aug;55(4):307–319. doi: 10.1159/000011868. [DOI] [PubMed] [Google Scholar]
  30. Ho S. B., Ewing S. L., Montgomery C. K., Kim Y. S. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence. Oncol Res. 1996;8(2):53–61. [PubMed] [Google Scholar]
  31. Ho S. B., Shekels L. L., Toribara N. W., Kim Y. S., Lyftogt C., Cherwitz D. L., Niehans G. A. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res. 1995 Jun 15;55(12):2681–2690. [PubMed] [Google Scholar]
  32. Israel E. J. Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosal barrier. Acta Paediatr Suppl. 1994;396:27–32. doi: 10.1111/j.1651-2227.1994.tb13238.x. [DOI] [PubMed] [Google Scholar]
  33. Itzkowitz S. H., Young E., Dubois D., Harpaz N., Bodian C., Chen A., Sachar D. B. Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology. 1996 Mar;110(3):694–704. doi: 10.1053/gast.1996.v110.pm8608878. [DOI] [PubMed] [Google Scholar]
  34. Itzkowitz S. H., Yuan M., Fukushi Y., Lee H., Shi Z. R., Zurawski V., Jr, Hakomori S., Kim Y. S. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues. Cancer Res. 1988 Jul 1;48(13):3834–3842. [PubMed] [Google Scholar]
  35. Itzkowitz S. H., Yuan M., Montgomery C. K., Kjeldsen T., Takahashi H. K., Bigbee W. L., Kim Y. S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989 Jan 1;49(1):197–204. [PubMed] [Google Scholar]
  36. Iwata H., Itzkowitz S. H., Werther J. L., Hayashi K., Nakamura H., Ichinose M., Miki K., Tatematsu M. Expression of sialosyl-Tn in intestinal type cancer cells of human gastric cancers. Acta Pathol Jpn. 1993 Nov;43(11):646–653. doi: 10.1111/j.1440-1827.1993.tb02548.x. [DOI] [PubMed] [Google Scholar]
  37. Jass J. R., Allison L. J., Edgar S. G. Distribution of sialosyl Tn and Tn antigens within normal and malignant colorectal epithelium. J Pathol. 1995 Jun;176(2):143–149. doi: 10.1002/path.1711760207. [DOI] [PubMed] [Google Scholar]
  38. Jass J. R. Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study. J Clin Pathol. 1981 Aug;34(8):866–870. doi: 10.1136/jcp.34.8.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jass J. R., Roberton A. M. Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int. 1994 Jul;44(7):487–504. doi: 10.1111/j.1440-1827.1994.tb02599.x. [DOI] [PubMed] [Google Scholar]
  40. Kim Y. S., Gum J., Jr, Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J. 1996 Oct;13(5):693–707. doi: 10.1007/BF00702333. [DOI] [PubMed] [Google Scholar]
  41. Kyo K., Parkes M., Takei Y., Nishimori H., Vyas P., Satsangi J., Simmons J., Nagawa H., Baba S., Jewell D. Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum Mol Genet. 1999 Feb;8(2):307–311. doi: 10.1093/hmg/8.2.307. [DOI] [PubMed] [Google Scholar]
  42. Lapertosa G., Baracchini P., Fulcheri E. Mucin histochemical analysis in the interpretation of Barrett's esophagus. Results of a multicenter study. The Operative Group for the Study of Esophageal Precancer. Am J Clin Pathol. 1992 Jul;98(1):61–66. doi: 10.1093/ajcp/98.1.61. [DOI] [PubMed] [Google Scholar]
  43. MacLean G. D., Reddish M. A., Longenecker B. M. Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J Immunother. 1997 Jan;20(1):70–78. doi: 10.1097/00002371-199701000-00008. [DOI] [PubMed] [Google Scholar]
  44. Mann B., Klussmann E., Vandamme-Feldhaus V., Iwersen M., Hanski M. L., Riecken E. O., Buhr H. J., Schauer R., Kim Y. S., Hanski C. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases. Int J Cancer. 1997 Jul 17;72(2):258–264. doi: 10.1002/(sici)1097-0215(19970717)72:2<258::aid-ijc10>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  45. Matsushita Y., Yamamoto N., Shirahama H., Tanaka S., Yonezawa S., Yamori T., Irimura T., Sato E. Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases. Jpn J Cancer Res. 1995 Nov;86(11):1060–1067. doi: 10.1111/j.1349-7006.1995.tb03021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. McCormick D. A., Horton L. W., Mee A. S. Mucin depletion in inflammatory bowel disease. J Clin Pathol. 1990 Feb;43(2):143–146. doi: 10.1136/jcp.43.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. McMahon R. F., Warren B. F., Jones C. J., Mayberry J. F., Probert C. S., Corfield A. P., Stoddart R. W. South Asians with ulcerative colitis exhibit altered lectin binding compared with matched European cases. Histochem J. 1997 Jun;29(6):469–477. doi: 10.1023/a:1026407505561. [DOI] [PubMed] [Google Scholar]
  48. Medina M., Vélez D., Asenjo J. A., Egea G., Real F. X., Gil J., Subiza J. L. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells. Cancer Res. 1999 Mar 1;59(5):1061–1070. [PubMed] [Google Scholar]
  49. Miller-Podraza H., Bergström J., Milh M. A., Karlsson K. A. Recognition of glycoconjugates by Helicobacter pylori. Comparison of two sialic acid-dependent specificities based on haemagglutination and binding to human erythrocyte glycoconjugates. Glycoconj J. 1997 Jun;14(4):467–471. doi: 10.1023/a:1018599401772. [DOI] [PubMed] [Google Scholar]
  50. Mullen P. J., Carr N., Milton J. D., Rhodes J. M. Immunohistochemical detection of O-acetylated sialomucins in intestinal metaplasia and carcinoma of the stomach. Histopathology. 1995 Aug;27(2):161–167. doi: 10.1111/j.1365-2559.1995.tb00024.x. [DOI] [PubMed] [Google Scholar]
  51. Myerscough N., Warren B., Gough M., Corfield A. Expression of mucin genes in ulcerative colitis. Biochem Soc Trans. 1995 Nov;23(4):536S–536S. doi: 10.1042/bst023536s. [DOI] [PubMed] [Google Scholar]
  52. Nakagawa K., Akagi J., Takai E., Tamori Y., Okino T., Kako H., Egami H., Ogawa M. Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. Int J Oncol. 1999 Mar;14(3):425–435. doi: 10.3892/ijo.14.3.425. [DOI] [PubMed] [Google Scholar]
  53. Nakamori S., Ota D. M., Cleary K. R., Shirotani K., Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology. 1994 Feb;106(2):353–361. doi: 10.1016/0016-5085(94)90592-4. [DOI] [PubMed] [Google Scholar]
  54. Newton J. L., Jordan N., Oliver L., Strugala V., Pearson J., James O. F., Allen A. Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut. 1998 Oct;43(4):470–475. doi: 10.1136/gut.43.4.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ogata S., Koganty R., Reddish M., Longenecker B. M., Chen A., Perez C., Itzkowitz S. H. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj J. 1998 Jan;15(1):29–35. doi: 10.1023/a:1006935331756. [DOI] [PubMed] [Google Scholar]
  56. Ogata S., Uehara H., Chen A., Itzkowitz S. H. Mucin gene expression in colonic tissues and cell lines. Cancer Res. 1992 Nov 1;52(21):5971–5978. [PubMed] [Google Scholar]
  57. Ohe Y., Hinoda Y., Irimura T., Imai K., Yachi A. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Jpn J Cancer Res. 1994 Apr;85(4):400–408. doi: 10.1111/j.1349-7006.1994.tb02373.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ota H., Nakayama J., Momose M., Hayama M., Akamatsu T., Katsuyama T., Graham D. Y., Genta R. M. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch. 1998 Nov;433(5):419–426. doi: 10.1007/s004280050269. [DOI] [PubMed] [Google Scholar]
  59. Probert C. S., Warren B. F., Perry T., Mackay E. H., Mayberry J. F., Corfield A. P. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut. 1995 May;36(5):696–702. doi: 10.1136/gut.36.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Pullan R. D., Thomas G. A., Rhodes M., Newcombe R. G., Williams G. T., Allen A., Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut. 1994 Mar;35(3):353–359. doi: 10.1136/gut.35.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Raouf A. H., Tsai H. H., Parker N., Hoffman J., Walker R. J., Rhodes J. M. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) 1992 Nov;83(5):623–626. doi: 10.1042/cs0830623. [DOI] [PubMed] [Google Scholar]
  62. Reis C. A., David L., Correa P., Carneiro F., de Bolós C., Garcia E., Mandel U., Clausen H., Sobrinho-Simões M. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999 Mar 1;59(5):1003–1007. [PubMed] [Google Scholar]
  63. Reis C. A., David L., Nielsen P. A., Clausen H., Mirgorodskaya K., Roepstorff P., Sobrinho-Simões M. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer. 1997 Feb 20;74(1):112–121. doi: 10.1002/(sici)1097-0215(19970220)74:1<112::aid-ijc19>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  64. Reis C. A., David L., Seixas M., Burchell J., Sobrinho-Simões M. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer. 1998 Aug 21;79(4):402–410. doi: 10.1002/(sici)1097-0215(19980821)79:4<402::aid-ijc16>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  65. Sakamoto H., Yonezawa S., Utsunomiya T., Tanaka S., Kim Y. S., Sato E. Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol. 1997 Sep;28(9):1056–1065. doi: 10.1016/s0046-8177(97)90059-9. [DOI] [PubMed] [Google Scholar]
  66. Shepherd N. A., Healey C. J., Warren B. F., Richman P. I., Thomson W. H., Wilkinson S. P. Distribution of mucosal pathology and an assessment of colonic phenotypic change in the pelvic ileal reservoir. Gut. 1993 Jan;34(1):101–105. doi: 10.1136/gut.34.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sidebotham R. L., Batten J. J., Karim Q. N., Spencer J., Baron J. H. Breakdown of gastric mucus in presence of Helicobacter pylori. J Clin Pathol. 1991 Jan;44(1):52–57. doi: 10.1136/jcp.44.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Slomiany B. L., Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol. 1992;14 (Suppl 1):S114–S121. [PubMed] [Google Scholar]
  69. Smith A. C., Podolsky D. K. Biosynthesis and secretion of human colonic mucin glycoproteins. J Clin Invest. 1987 Aug;80(2):300–307. doi: 10.1172/JCI113073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Smithson J. E., Campbell A., Andrews J. M., Milton J. D., Pigott R., Jewell D. P. Altered expression of mucins throughout the colon in ulcerative colitis. Gut. 1997 Feb;40(2):234–240. doi: 10.1136/gut.40.2.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Springer G. F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J Mol Med (Berl) 1997 Aug;75(8):594–602. doi: 10.1007/s001090050144. [DOI] [PubMed] [Google Scholar]
  72. Teitelbaum D. H., Caniano D. A., Qualman S. J. The pathophysiology of Hirschsprung's-associated enterocolitis: importance of histologic correlates. J Pediatr Surg. 1989 Dec;24(12):1271–1277. doi: 10.1016/s0022-3468(89)80566-4. [DOI] [PubMed] [Google Scholar]
  73. Torrado J., Ruiz B., Garay J., Asenjo J. L., Tovar J. A., Cosme A., Correa P. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol. 1997 Sep;21(9):1023–1029. doi: 10.1097/00000478-199709000-00006. [DOI] [PubMed] [Google Scholar]
  74. Torrado J., Ruiz B., Garay J., Cosme A., Arenas J. I., Bravo J. C., Fontham E., Correa P. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia. Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):287–289. [PubMed] [Google Scholar]
  75. Tytgat K. M., van der Wal J. W., Einerhand A. W., Büller H. A., Dekker J. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun. 1996 Jul 16;224(2):397–405. doi: 10.1006/bbrc.1996.1039. [DOI] [PubMed] [Google Scholar]
  76. Utsunomiya T., Yonezawa S., Sakamoto H., Kitamura H., Hokita S., Aiko T., Tanaka S., Irimura T., Kim Y. S., Sato E. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res. 1998 Nov;4(11):2605–2614. [PubMed] [Google Scholar]
  77. Van Klinken B. J., Dekker J., Büller H. A., Einerhand A. W. Mucin gene structure and expression: protection vs. adhesion. Am J Physiol. 1995 Nov;269(5 Pt 1):G613–G627. doi: 10.1152/ajpgi.1995.269.5.G613. [DOI] [PubMed] [Google Scholar]
  78. Van Klinken B. J., Van der Wal J. W., Einerhand A. W., Büller H. A., Dekker J. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut. 1999 Mar;44(3):387–393. doi: 10.1136/gut.44.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Weiss A. A., Babyatsky M. W., Ogata S., Chen A., Itzkowitz S. H. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem. 1996 Oct;44(10):1161–1166. doi: 10.1177/44.10.8813081. [DOI] [PubMed] [Google Scholar]
  80. Werther J. L., Tatematsu M., Klein R., Kurihara M., Kumagai K., Llorens P., Guidugli Neto J., Bodian C., Pertsemlidis D., Yamachika T. Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study. Int J Cancer. 1996 Jun 21;69(3):193–199. doi: 10.1002/(SICI)1097-0215(19960621)69:3<193::AID-IJC8>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  81. Williams S. J., McGuckin M. A., Gotley D. C., Eyre H. J., Sutherland G. R., Antalis T. M. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res. 1999 Aug 15;59(16):4083–4089. [PubMed] [Google Scholar]
  82. Yamori T., Kimura H., Stewart K., Ota D. M., Cleary K. R., Irimura T. Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases. Cancer Res. 1987 May 15;47(10):2741–2747. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES